11-7001199-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000278314.5(ZNF214):āc.484T>Cā(p.Phe162Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000255 in 1,613,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000278314.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF214 | NM_013249.4 | c.484T>C | p.Phe162Leu | missense_variant | 3/3 | ENST00000278314.5 | NP_037381.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF214 | ENST00000278314.5 | c.484T>C | p.Phe162Leu | missense_variant | 3/3 | 1 | NM_013249.4 | ENSP00000278314.4 | ||
ZNF214 | ENST00000536068.5 | c.484T>C | p.Phe162Leu | missense_variant | 4/4 | 1 | ENSP00000445373.1 |
Frequencies
GnomAD3 genomes AF: 0.000178 AC: 27AN: 151802Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 251028Hom.: 0 AF XY: 0.0000958 AC XY: 13AN XY: 135690
GnomAD4 exome AF: 0.000263 AC: 385AN: 1461182Hom.: 0 Cov.: 76 AF XY: 0.000250 AC XY: 182AN XY: 726904
GnomAD4 genome AF: 0.000178 AC: 27AN: 151920Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74282
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2023 | The c.484T>C (p.F162L) alteration is located in exon 3 (coding exon 2) of the ZNF214 gene. This alteration results from a T to C substitution at nucleotide position 484, causing the phenylalanine (F) at amino acid position 162 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at